Prestige Consumer Healthcare Inc reports results for the quarter ended June 30 - Earnings Summary
Prestige Consumer Healthcare Inc reports results for the quarter ended June 30 - Earnings Summary
Prestige Consumer Healthcare Inc PBH.N reported quarterly adjusted earnings of 98 cents per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of 95 cents. The mean expectation of seven analysts for the quarter was for earnings of 88 cents per share. Wall Street expected results to range from 87 cents to 92 cents per share.
Revenue rose 6.5% to $265.71 million from a year ago; analysts expected $250.33 million.
Prestige Consumer Healthcare Inc's reported EPS for the quarter was 61 cents.
The company reported quarterly net income of $29.18 million.
Prestige Consumer Healthcare Inc shares had risen by 12.1% this quarter and lost 14.1% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had fallen by about 11.3% in the last three months.
In the last 30 days, there have been no negative revisions of earnings estimates
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell." The average consensus recommendation for the pharmaceuticals peer group is also "buy"
Wall Street's median 12-month price target for Prestige Consumer Healthcare Inc is $69.50, about 23.8% above its last closing price of $52.98
This summary was machine generated from LSEG data August 6 at 01:31 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
Jun. 30 2026 | 0.88 | 0.98 | Beat |
Mar. 31 2026 | 1.39 | 1.23 | Missed |
Dec. 31 2025 | 1.14 | 1.14 | Met |
Sep. 30 2025 | 0.97 | 1.07 | Beat |
Recent news on Prestige Consumer Healthcare
See all newsPrestige Consumer Healthcare Inc. reports results for the quarter ended September 30 - Earnings Summary
Prestige Consumer Healthcare Q2 revenue beats on acquisition boost
Prestige Consumer Healthcare Inc reports results for the quarter ended June 30 - Earnings Summary
Prestige Consumer Healthcare beats Q1 revenue estimates, raises 2027 outlook
Brief: Prestige Consumer Healthcare Inc. Announces Offering Of $400 Million Senior Notes